Home › Cirrhosis › Maryland
Cirrhosis clinical trials in Maryland
4 studies for Cirrhosis are looking for participants at sites in Maryland.
Cities in Maryland
LIVERAGEâ„¢: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Mercy Medical Center, Baltimore
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06632444A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
- Johns Hopkins Hospital, Baltimore
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 30, 2026 · NCT07325526Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- University of Maryland School of Medicine, Baltimore
RecruitingObservational study
Ages 18 to 80 · All sexes · Updated Oct 20, 2025 · NCT04613921Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
- Mercy Medical Center, Baltimore
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Nov 19, 2024 · NCT04588077From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.